Since its inception, the International Journal of Pharmaceutical Compounding (IJPC) has stood as a beacon of excellence, dedicated to advancing the art of compounding envisioned by Dr. Allen. As we look forward, it is evident that our mission to serve as the leading resource for the compounding industry remains as vital as ever.

Dr. Allen's vision for this journal was rooted in pursuing innovation and promoting best practices within compounding. Today, this vision guides us through an era where advancements in technology, evolving regulatory landscapes such as USP guidelines, and an increasing demand for specialized pharmaceutical formulations define our industry. IJPC is uniquely positioned to help compounding pharmacists navigate these complexities, offering a peer-reviewed platform that ensures the dissemination of cutting-edge research and insights.

In recent years, the compounding industry has faced unprecedented challenges as well as opportunities. From the most basic to the most complex dosage forms, the need for reliable information and evidence-based practices has intensified. Our commitment to rigorous peer review ensures that the highest quality research and methodologies are published, providing practitioners, researchers, and regulators alike with invaluable guidance.

As part of our commitment to fulfilling this mission, IJPC, Inc. is establishing comprehensive plans to expand our reach and enhance our offerings. This includes special issues focused on emerging trends and enhancing our digital presence to make content relevant and accessible to our global audience. By fostering dialogue among experts in the industry and continuously evolving to meet the needs of the compounding community, we ensure that the journal remains at the forefront of industry advancements.

Looking ahead, we are optimistic about the role of IJPC in shaping the future of pharmaceutical compounding. With your contributions and our dedication to excellence, we will continue to advance Dr. Allen's vision, setting benchmarks in research integrity and professional practice. Together, we will navigate the complexities of our industry with confidence, knowing that through shared knowledge and unwavering commitment, we will chart a course toward a brighter future for pharmaceutical compounding.

Thomas C. Kupiec, Ph.D. President 405.271.1144 Phone 122 N. Bryant Avenue, Suite B4 Edmond, OK 73034 tkupiec@ijpc.com https://ijpc.com  https://CompoundingToday.com

Post Your Job Listings to the CNL!

Compounders' Network List (CNL) members can post job openings and positions wanted on the CNL every Friday!

The CNL is a peer-to-peer group via moderated emails. Send your job related posts each Friday to Network@lists.ijpc.com. Just be sure you are a part of our list serve community.

From Out of the Past

If you don't know
Whose signs these are
You haven't driven
Very far!
     Burma-Shave

Thanks to our advertisers in this featured Jul/Aug 2024 issue. Please support them when possible.